Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction ...Middle East

TAIPEI, Dec. 16, 2023 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over $100M by issuing 8 million new shares. The new funding will enable Caliway to advance the clinical development of its lead pipeline...

Hence then, the article about caliway closes oversubscribed capital raise and secures over 100m to advance cbl 514 pivotal phase 3 study in subcutaneous fat reduction was published today ( Saturday 16/12/2023 - 10:49 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Caliway Closes Oversubscribed Capital Raise and Secures Over $100M to Advance CBL-514 Pivotal Phase 3 Study in Subcutaneous Fat Reduction )

Also on site :

• Bran Flakezz on Winning ‘Unwell Summer Games,’ His Future With Reality TV and the Alex Cooper-Alix Earle Drama
• Robert De Niro’s Best Movie According to Critics Is a Surprising 1985 Cult Classic With a Kate Bush Connection
• 1963 Movie Starring Two TV Icons Was So Bad They Joked About It on ‘The Carol Burnett’ Show Years Later